FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2099692303> ?p ?o ?g. }

• W2099692303 endingPage "721" @default.
• W2099692303 startingPage "716" @default.
• W2099692303 abstract "We hypothesized that a response to pegylated liposomal doxorubicin (PLD, Caelyx/Doxil) followed by maintenance is beneficial and safe in recurrent ovarian cancer.Sixteen patients have received PLD for more than 1 year for recurrent ovarian (14) or fallopian tube (2) cancer. All had stable disease or better responses to PLD + carboplatin (5) or topotecan (9) doublets or to PLD alone (2). PLD maintenance therapy 30-40 mg/m(2) was given every 4-8 weeks. This analysis focuses on cardiac status, overall tolerance, and time to recurrence.Termination of PLD was due to progression in all patients. Noteworthy was the lack of cumulative myelosuppression and, with one exception, clinical cardiac toxicity. This patient was hospitalized with cardiogenic shock and fever complicating grade 4 pancytopenia from topotecan ten months after discontinuation of PLD. Seven patients continue to receive PLD after a median of 1680 mg/m(2) (1180-2460 mg/m(2)). Four of these had documented relapses after 3-6 years on maintenance occurring in the setting of lengthening of the treatment interval. Maintenance PLD was reinstituted after 'reinduction' with a platinum.PLD appears to be safe as long-term maintenance in ovarian cancer and may be important for a continued response." @default.
• W2099692303 created "2016-06-24" @default.
• W2099692303 creator A5003104262 @default.
• W2099692303 creator A5003255219 @default.
• W2099692303 creator A5012143202 @default.
• W2099692303 creator A5013368100 @default.
• W2099692303 creator A5028410044 @default.
• W2099692303 creator A5043240282 @default.
• W2099692303 creator A5047607436 @default.
• W2099692303 creator A5068302986 @default.
• W2099692303 creator A5068790150 @default.
• W2099692303 date "2007-04-01" @default.
• W2099692303 modified "2023-10-15" @default.
• W2099692303 title "Pegylated liposomal doxorubicin HCL (PLD; Caelyx/Doxil®): Experience with long-term maintenance in responding patients with recurrent epithelial ovarian cancer" @default.
• W2099692303 cites W1892622076 @default.
• W2099692303 cites W1966943069 @default.
• W2099692303 cites W1975298683 @default.
• W2099692303 cites W2005161501 @default.
• W2099692303 cites W2012405585 @default.
• W2099692303 cites W2019995515 @default.
• W2099692303 cites W2031858825 @default.
• W2099692303 cites W2035803535 @default.
• W2099692303 cites W2037064988 @default.
• W2099692303 cites W2044421413 @default.
• W2099692303 cites W2055892918 @default.
• W2099692303 cites W2071048538 @default.
• W2099692303 cites W2074544404 @default.
• W2099692303 cites W2079537409 @default.
• W2099692303 cites W2082992386 @default.
• W2099692303 cites W2094202153 @default.
• W2099692303 cites W2096593771 @default.
• W2099692303 cites W2102282448 @default.
• W2099692303 cites W2105878476 @default.
• W2099692303 cites W2126333580 @default.
• W2099692303 cites W2139248078 @default.
• W2099692303 cites W2148845753 @default.
• W2099692303 cites W2160684474 @default.
• W2099692303 cites W2169253572 @default.
• W2099692303 cites W2202035925 @default.
• W2099692303 cites W2245111413 @default.
• W2099692303 cites W34190750 @default.
• W2099692303 cites W4239651622 @default.
• W2099692303 cites W4248831562 @default.
• W2099692303 doi "https://doi.org/10.1093/annonc/mdl484" @default.
• W2099692303 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17301073" @default.
• W2099692303 hasPublicationYear "2007" @default.
• W2099692303 type Work @default.
• W2099692303 sameAs 2099692303 @default.
• W2099692303 citedByCount "71" @default.
• W2099692303 countsByYear W20996923032012 @default.
• W2099692303 countsByYear W20996923032013 @default.
• W2099692303 countsByYear W20996923032014 @default.
• W2099692303 countsByYear W20996923032015 @default.
• W2099692303 countsByYear W20996923032016 @default.
• W2099692303 countsByYear W20996923032017 @default.
• W2099692303 countsByYear W20996923032018 @default.
• W2099692303 countsByYear W20996923032019 @default.
• W2099692303 countsByYear W20996923032020 @default.
• W2099692303 countsByYear W20996923032021 @default.
• W2099692303 countsByYear W20996923032022 @default.
• W2099692303 countsByYear W20996923032023 @default.
• W2099692303 crossrefType "journal-article" @default.
• W2099692303 hasAuthorship W2099692303A5003104262 @default.
• W2099692303 hasAuthorship W2099692303A5003255219 @default.
• W2099692303 hasAuthorship W2099692303A5012143202 @default.
• W2099692303 hasAuthorship W2099692303A5013368100 @default.
• W2099692303 hasAuthorship W2099692303A5028410044 @default.
• W2099692303 hasAuthorship W2099692303A5043240282 @default.
• W2099692303 hasAuthorship W2099692303A5047607436 @default.
• W2099692303 hasAuthorship W2099692303A5068302986 @default.
• W2099692303 hasAuthorship W2099692303A5068790150 @default.
• W2099692303 hasBestOaLocation W20996923031 @default.
• W2099692303 hasConcept C121608353 @default.
• W2099692303 hasConcept C126322002 @default.
• W2099692303 hasConcept C141071460 @default.
• W2099692303 hasConcept C143998085 @default.
• W2099692303 hasConcept C2776694085 @default.
• W2099692303 hasConcept C2776850375 @default.
• W2099692303 hasConcept C2778043895 @default.
• W2099692303 hasConcept C2778239845 @default.
• W2099692303 hasConcept C2778283404 @default.
• W2099692303 hasConcept C2778715236 @default.
• W2099692303 hasConcept C2780192828 @default.
• W2099692303 hasConcept C2780427987 @default.
• W2099692303 hasConcept C2781209748 @default.
• W2099692303 hasConcept C2781451048 @default.
• W2099692303 hasConcept C500558357 @default.
• W2099692303 hasConcept C71924100 @default.
• W2099692303 hasConceptScore W2099692303C121608353 @default.
• W2099692303 hasConceptScore W2099692303C126322002 @default.
• W2099692303 hasConceptScore W2099692303C141071460 @default.
• W2099692303 hasConceptScore W2099692303C143998085 @default.
• W2099692303 hasConceptScore W2099692303C2776694085 @default.
• W2099692303 hasConceptScore W2099692303C2776850375 @default.
• W2099692303 hasConceptScore W2099692303C2778043895 @default.
• W2099692303 hasConceptScore W2099692303C2778239845 @default.
• W2099692303 hasConceptScore W2099692303C2778283404 @default.
• W2099692303 hasConceptScore W2099692303C2778715236 @default.

• next